Physiological and pharmacological modulation of BAX is a research paper published in Trends in Pharmacological Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 296 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: P30AG038072
NIH
Grant: P30CA013330
DOD
Grant: PR191593P1
Pershing Square Sohn Cancer Research Alliance
Grant: F30CA228453
Pershing Square Sohn Cancer Research Alliance
Grant: T32GM007288
NIA NIH HHS
Grant: P01 AG031782
NCI NIH HHS
Grant: R01 CA178394
National Institutes of Health
Grant: 5P30AG038072-14
Einstein's Nathan Shock Center of Excellence in Basic Biology of Aging
National Institutes of Health
Grant: 5F30CA228453-03
Direct Small Molecule Activation of Pro-apoptotic BAK
National Institutes of Health
Grant: 5R01CA178394-08
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
National Institutes of Health
Grant: 3P30CA013330-39S3
Core Support for Cancer Center
National Institutes of Health
Grant: 2T32GM007288-24
MEDICAL SCIENTIST TRAINING PROGRAM
National Institutes of Health
Grant: 5P01AG031782-07
Aging and Transgenic Animal Core (Core C)
Irma T. Hirschl Trust
FWCI
11.99
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Integrated metabolomics, network pharmacology and biological verification to reveal the mechanisms of Nauclea officinalis treatment of LPS-induced acute lung injury
Additional file 1 of Integrated metabolomics, network pharmacology and biological verification to reveal the mechanisms of Nauclea officinalis treatment of LPS-induced acute lung injury
Additional file 2 of Integrated metabolomics, network pharmacology and biological verification to reveal the mechanisms of Nauclea officinalis treatment of LPS-induced acute lung injury
Additional file 2 of Integrated metabolomics, network pharmacology and biological verification to reveal the mechanisms of Nauclea officinalis treatment of LPS-induced acute lung injury
Additional file 3 of Integrated metabolomics, network pharmacology and biological verification to reveal the mechanisms of Nauclea officinalis treatment of LPS-induced acute lung injury
Additional file 3 of Integrated metabolomics, network pharmacology and biological verification to reveal the mechanisms of Nauclea officinalis treatment of LPS-induced acute lung injury
Additional file 5 of Integrated metabolomics, network pharmacology and biological verification to reveal the mechanisms of Nauclea officinalis treatment of LPS-induced acute lung injury
Additional file 5 of Integrated metabolomics, network pharmacology and biological verification to reveal the mechanisms of Nauclea officinalis treatment of LPS-induced acute lung injury
Additional file 1 of Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification
Additional file 1 of Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification
Additional file 4 of Integrated metabolomics, network pharmacology and biological verification to reveal the mechanisms of Nauclea officinalis treatment of LPS-induced acute lung injury
Additional file 4 of Integrated metabolomics, network pharmacology and biological verification to reveal the mechanisms of Nauclea officinalis treatment of LPS-induced acute lung injury